Sensitization and cross-sensitization after chronic treatment with methylphenidate in adolescent Wistar rats
The DOI matches its Crossref record; 13 of the 13 references it cites were found in a registry or an index.
Abstract
An increasing debate exists about the potential of early exposure to methylphenidate to increase the risk for drug abuse. In addition, little is known about the neurobiological effects of early exposure to methylphenidate. This study was designed to investigate whether chronic treatment with methylphenidate induces behavioral sensitization to subsequent methylphenidate and D-amphetamine challenge in adolescent Wistar rats. Young Wistar rats (P25) were treated with either methylphenidate (1, 2, or 10 mg/kg, intraperitoneally) or saline for 28 days. After 14 days of washout, animals were challenged with methylphenidate 2.5 mg/kg intraperitoneally or D-amphetamine 2 mg/kg intraperitoneally (P67). Locomotor behavior was assessed using the open field test. Rats chronically treated with methylphenidate in the adolescent period showed augmented locomotor sensitization to D-amphetamine but not to methylphenidate in the adult phase. These findings suggest that early exposure do methylphenidate might increase the risk for subsequent D-amphetamine abuse. Further studies focusing on the neurobiological effects of early exposure to methylphenidate are warranted.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Kessler, R. C., Adler, L., Barkley, R., Biederman, J., Conners, C. K., Demler, O., Faraone, S. V., Greenhill, L. L., Howes, M. J., Secnik, K., et al. (2006) · American Journal of Psychiatry · doi:10.1176/ajp.2006.163.4.716 · Cited by 3,886 · cited 2×
“4% and may be associated with increased substance-related disorders (Kessler et al., 2006).”
BackgroundInfluentialIs there a common molecular pathway for addiction?
Nestler, E. J. (2005) · Nature Neuroscience · doi:10.1038/nn1578 · Cited by 1,388 · cited 4×
“Given that chronic exposure to psychostimulants induces cellular and molecular adaptations that parallel behavioral sensitization and associative learning toward drug-related cues (White and Kalivas, 1998; Nestler, 2005), this finding suggests that early treatment with MPD may increase the risk for amphetamine abuse.”
BackgroundInfluentialDiagnosis and Treatment of Attention-Deficit/Hyperactivity Disorder in Children and Adolescents
Goldman, L. S. (1998) · JAMA · doi:10.1001/jama.279.14.1100 · Cited by 1,082
BIEDERMAN, J., MONUTEAUX, M. C., MICK, E., SPENCER, T., WILENS, T. E., SILVA, J. M., SNYDER, L. E., & FARAONE, S. V. (2006) · Psychological Medicine · doi:10.1017/s0033291705006410 · Cited by 850
Kuczenski, R., & Segal, D. S. (1997) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1997.68052032.x · Cited by 623 · cited 2×
“The peak of extracellular dopamine increase for MPD and AMPH when administered intraperitoneally occurs between 30 and 35 min (Schiffer et al., 2006), and the temporal responses of extracellular dopamine between MPD and AMPH are parallel (Kuczenski and Segal, 1997).”
BackgroundKrause, K.-H., Dresel, S. H., Krause, J., Kung, H. F., & Tatsch, K. (2000) · Neuroscience Letters · doi:10.1016/s0304-3940(00)01040-5 · Cited by 521 · cited 1×
“It has been suggested that long-term psychostimulant administration might decrease dopamine transporter density (Wilson et al., 1996; Krause et al., 2000).”
BackgroundBIEDERMAN, J., WILENS, T., MICK, E., FARAONE, S. V., WEBER, W., CURTIS, S., THORNELL, A., PFISTER, K., JETTON, J. G., & SORIANO, J. (1997) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/00004583-199701000-00013 · Cited by 476
Kuczenski, R., & Segal, D. S. (2002) · The Journal of Neuroscience · doi:10.1523/jneurosci.22-16-07264.2002 · Cited by 316 · cited 8×
“Two other studies, however, failed to demonstrate cross-sensitization between MPD and cocaine (Guerriero et al., 2006) or methamphetamine (Kuczenski and Segal, 2002).”
BackgroundResultInfluentialWindows of vulnerability to psychopathology and therapeutic strategy in the adolescent rodent model
Adriani, W., & Laviola, G. (2004) · Behavioural Pharmacology · doi:10.1097/00008877-200409000-00005 · Cited by 267 · cited 2×
“Here, it is worth noting that the definition of adolescence in rodents has been controversial (Spear, 2000; Carlezon and Konradi, 2004), and the age-limits of this phase are considered to be indicative rather than strict (Adriani and Laviola, 2004).”
BackgroundAltered responsiveness to cocaine in rats exposed to methylphenidate during development
Andersen, S. L., Arvanitogiannis, A., Pliakas, A. M., LeBlanc, C., & Carlezon, W. A. (2002) · Nature Neuroscience · doi:10.1038/nn777 · Cited by 259 · cited 2×
“Using the conditioned place preference paradigm, two studies found that MPD exposure to adolescent rats diminished responsiveness to the rewarding effects of cocaine, and enhanced aversive behavior to cocaine in the adulthood (Andersen et al., 2002; Carlezon et al., 2003).”
BackgroundMethodBrandon, C. (2001) · Neuropsychopharmacology · doi:10.1016/s0893-133x(01)00281-0 · Cited by 259
Enduring behavioral effects of early exposure to methylphenidate in rats
Carlezon, W. A., Mague, S. D., & Andersen, S. L. (2003) · Biological Psychiatry · doi:10.1016/j.biopsych.2003.08.020 · Cited by 248
Schiffer, W. K., Volkow, N. D., Fowler, J. S., Alexoff, D. L., Logan, J., & Dewey, S. L. (2006) · Synapse · doi:10.1002/syn.20235 · Cited by 134 · cited 2×
“The peak of extracellular dopamine increase for MPD and AMPH when administered intraperitoneally occurs between 30 and 35 min (Schiffer et al., 2006), and the temporal responses of extracellular dopamine between MPD and AMPH are parallel (Kuczenski and Segal, 1997).”
Background
Cited by
Molina, B. S. G., Hinshaw, S. P., Eugene Arnold, L., Swanson, J. M., Pelham, W. E., Hechtman, L., Hoza, B., Epstein, J. N., Wigal, T., Abikoff, H. B., et al. (2013) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1016/j.jaac.2012.12.014 · Cited by 246
“This possibility, potentially linked to the overlap in brain-based mechanisms for both addictive behaviors and stimulant medication efficacy,(14) has been supported, with mixed results, in animal studies, showing an enhanced response to drugs of abuse following methylphenidate exposure.(15) However, route of administr…”
ResultSadasivan, S., Pond, B. B., Pani, A. K., Qu, C., Jiao, Y., & Smeyne, R. J. (2012) · PLoS ONE · doi:10.1371/journal.pone.0033693 · Cited by 102
“mirror those that are used in clinical practice [26], whereas recreational use of MPH or its use in the treatment of narcolepsy would be reflected by a dose of 10 mg/kg [27].”
BackgroundMethodCocaine responsiveness or anhedonia in rats treated with methylphenidate during adolescence
Ferguson, S. A., & Boctor, S. Y. (2010) · Neurotoxicology and Teratology · doi:10.1016/j.ntt.2010.03.007 · Cited by 23
Metadata
- Authors
- Valvassori, S. S., Frey, B. N., Martins, M. R., Réus, G. Z., Schimidtz, F., Inácio, C. G., Kapczinski, F., & Quevedo, J.
- Venue
- Behavioural Pharmacology
- Published
- 2007-05
- Volume
- 18
- Issue
- 3
- Pages
- 205-212
- ISSN
- 0955-8810 (ISSN-L)
- OpenAlex
- W1994956163
- Cited by
- 47
- References
- 13
- FWCI
- 2.42
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.